Huron Consulting poised to hit fresh record ahead of S&P SmallCap addition
BUZZ-Huron Consulting poised to hit fresh record ahead of S&P SmallCap addition ** Shares of professional services firm Huron Consulting Group HURN.O up 4.5% at $202 premarket on Fri as it's set to be added to S&P SmallCap 600 Index .SPCY
** Stock rose for third straight session on Thurs, finishing up ~5.5% at fresh record high close of $193.35
** HURN to replace Supernus Pharmaceuticals SUPN.O in SPCY effective Mon, Nov 2, S&P Dow Jones Indices announced late Thurs
** SUPN slated to merge with Indivior Pharmaceuticals INDV.O to create a diversified central nervous system biopharma firm
** Stephens analyst Melissa Roberts said in a note she expects passive funds will need to purchase 2.1 mln HURN shares, which implies nearly 8 days of buying demand
** Chicago, Illinois-based HURN has ~15.9 mln shares outstanding for roughly $3 bln market cap
** Stock has rallied sharply from its 2026 intraday low of $84.88 hit on June 22, leaving it up ~12% YTD
** 3 analysts rate the stock "strong buy", 2 rate "buy"; median PT of $214 up from $194 a month ago, per LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Recent news on Indivior Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Indivior Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Supernus soars on Indivior merger, Q2 revenue beat
Supernus, Indivior merge to strengthen neuroscience drug portfolio
Indivior Pharmaceuticals beats Q2 revenue on Sublocade growth, raises FY guidance